Insulin, when used as an off-label treatment for Cluster Headache, is hypothesized to potentially interrupt the pathophysiological cascade of the headache through its effects on neurovascular regulation and metabolic pathways. Its proposed mechanism involves modulating cerebral glucose metabolism, potentially reducing neurogenic inflammation and altering vascular tone, which may help abort or reduce the severity of cluster headache episodes.